Quick Answer
Jade Biosciences, Inc. reported Total Assets of $349.78 million for the year ending 2025.
- Jade Biosciences, Inc. showed an increase of +380.5% in Total Assets from 2024 to 2025.
- This data is from Jade Biosciences, Inc.'s annual report (Form 10-K), filed with the SEC on March 6, 2026.
- XBRL data for this metric is available from 2020 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2021: $62.43 million | Q3 2021: $184.13 million | Q1 2022: $167.00 million | Q2 2022: $155.68 million | Q3 2022: $147.66 million | Q1 2023: $124.39 million | Q2 2023: $155.76 million | Q3 2023: $140.88 million | Q1 2024: $106.82 million | Q2 2024: $111.69 million | Q3 2024: $90.96 million | Q1 2025: $77.53 million | Q2 2025: $223.97 million | Q3 2025: $202.45 million.
- Over the full 6 years of available data (2020 to 2025), Jade Biosciences, Inc.'s Total Assets has grown by 7,318.5%.
- Historical annual values: Fiscal year 2025: $349.78 million | Fiscal year 2024: $72.80 million | Fiscal year 2023: $127.42 million | Fiscal year 2022: $135.30 million | Fiscal year 2021: $175.36 million | Fiscal year 2020: $4.72 million.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: